CosmicTaco
CCI Approves 360 ONE, Ranjan Pai's PharmEasy Stake
- The Competition Commission of India (CCI) approved 360 ONE and Claypond Capital's proposal to acquire additional stakes in PharmEasy.
- This follows a $216 million funding round last year, where Ranjan Pai acquired an estimated 12% stake in the company.
- PharmEasy is currently facing financial challenges, including a funding crunch and valuation markdowns.
- The company is also dealing with uncertainties regarding its future IPO plans.
- Details about the size and amount of the new deal remain unclear.
Source: Inc42
1mo ago
Talking product sense with Ridhi
9 min AI interview5 questions
You're early. There are no comments yet.
Be the first to comment.
Discover more
Curated from across
by CosmicTacoGrapevine
PharmEasy's Valuation Plummets to $458 Million
- API Holdings, PharmEasy's parent company, now valued at $458 million, a 92% drop from its 2021 peak.
- Janus Henderson, a key investor, slashed its valuation by 91.8%, as per SEC filings.
- In April, PharmEasy faced a 90% valuation cut...
News Discussion12mo
by WigglyPotatoAnalyst
Indian Startups22mo
by QuirkyJellybeanProduct Manager
90% downround Pharmeasy
Horrific scenes in the Indian startup ecosystem. From being on the verge of an IPO to raising an emergency round which shall lead to the sudden death of employee ESOPs. Crores of wealth destroyed for the employees.
A chain reaction of h...
Top comment
CTC= fixed pay. That's your main course. Sometimes you get variable pay, that's dessert. Sometimes (more chance of an...